Search:
Tokushima UniversityGraduate School of Biomedical Sciences歯学域Oral ScienceClinical DentistryDepartment of Orthodontics and Dentofacial Orthopedics
Tokushima UniversityUniversity HospitalClinical DivisionDepartment of Orthodontics
Tokushima UniversityFaculty of DentistryCourse in DentistryClinical Dentistry for Promotion and DevelopmentOrthodontics and Dentofacial Orthodontics
(Files for researchmap) [PDF manual] [Auto-propagate to researchmap]

Research Activity

Field of Study

Subject of Study

Book / Paper

Book:

1. Deguchi Toru and Keiichiro Watanabe :
Chapter 13 Application of Buccal TADs for Distalization of Teeth,
Elsevier, Jan. 2020.
2. Aki Ichihara, Keiichiro Watanabe, Shinya Horiuchi and Eiji Tanaka :
アンカースクリューによって|3埋伏歯の開窓牽引を行った症例,
Ishiyaku Publishers,Inc., Tokyo, 2019.
3. Eiji Tanaka, Hirofumi Tenshin, Hiroki Mori and Keiichiro Watanabe :
B-maxスクリュー Type-TKを用いた成人開咬の治療戦略,
クインテッセンス出版株式会社, Tokyo, 2018.

Academic Paper (Judged Full Paper):

1. Andrea E. Tsatalis, Keiichiro Watanabe, Bobby Mitchell, Do-Gyoon Kim, Damian J. Lee, Fengyuan Zheng, Hee-Moon Kyung and Toru Deguchi :
Mechanical and clinical evaluation of the effect of microscrew on root proximity and cortical bone thickness.,
European Journal of Orthodontics, Vol.42, No.2, 206-210, 2020.
(DOI: 10.1093/ejo/cjz017,   PubMed: 31075176)
2. H Zhang, M B. Chavez, T N. Kolli, M H. Tan, H Fong, E Y. Chu, Y Li, X Ren, Keiichiro Watanabe, D G. Kim and B L. Foster :
Dentoalveolar Defects in the Mouse Model of X-linked Hypophosphatemia.,
Journal of Dental Research, Vol.99, No.4, 419-428, 2020.
(DOI: 10.1177/0022034520901719,   PubMed: 31977267)
3. Aki Ichihara, Shinya Horiuchi, Naoko Ogasawara, Hiroki Mori, Ryota Amachi, Keiichiro Watanabe, Nao Kinouchi, Akihiro Yasue and Eiji Tanaka :
徳島大学病院矯正歯科における口唇裂・口蓋裂患者の永久歯の歯数異常に関する調査,
The Journal of Chu-Shikoku Orthodontic Society, Vol.30, No.1, 51-58, 2018.
4. Nao Kinouchi, Shinya Horiuchi, Akihiro Yasue, Yuko Kuroda, Nobuhiko Kawai, Keiichiro Watanabe, Takashi Izawa, Ichiro Hashimoto, H Ali Hassan and Eiji Tanaka :
Effectiveness of presurgical nasoalveolar molding therapy on unilateral cleft lip nasal deformity.,
Saudi Medical Journal, Vol.39, No.2, 169-178, 2018.
(Tokushima University Institutional Repository: 113505,   DOI: 10.15537/smj.2018.2.21020,   PubMed: 29436566)
5. Takafumi Susami, Toshihiko Fukawa, Haruyo Miyazaki, Teruo Sakamoto, Tadashi Morishita, Yoshiaki Sato, Yoshiaki Kinno, Kazuyuki Kurata, Keiichiro Watanabe, Toshikazu Asahito and Isao Saito :
A Survey of Orthodontic Treatment in Team Care for Patients With Syndromic Craniosynostosis in Japan.,
Cleft Palate-Craniofacial Journal, Vol.55, No.4, 479-486, 2018.
(DOI: 10.1177/1055665617747703,   PubMed: 29351022)
6. Hirofumi Tenshin, Jumpei Teramachi, Asuka Oda, Ryota Amachi, Masahiro Hiasa, Ariunzaya Bat-Erdene, Keiichiro Watanabe, Masami Iwasa, Takeshi Harada, Shiroh Fujii, Kumiko Kagawa, Kimiko Sogabe, Shingen Nakamura, Hirokazu Miki, Kiyoe Kurahashi, Sumiko Yoshida, Kenichi Aihara, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effects.,
Blood Advances, Vol.1, No.24, 2124-2137, 2017.
(Tokushima University Institutional Repository: 111724,   DOI: 10.1182/bloodadvances.2017008813,   PubMed: 29296860)
7. Ryota Amachi, Keiichiro Watanabe, Akihiro Yasue, Nobuhiko Kawai, Shinya Horiuchi and Eiji Tanaka :
歯科矯正用アンカースクリューを用いて上下歯列遠心移動を行った三年保定症例,
The Journal of Chu-Shikoku Orthodontic Society, Vol.29, No.1, 37-48, 2017.
8. Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, Takeshi Harada, Asuka Oda, Shingen Nakamura, Derek Hanson, Keiichiro Watanabe, Shiroh Fujii, Hirokazu Miki, Kumiko Kagawa, Masami Iwasa, Itsuro Endo, Takeshi Kondo, Sumiko Yoshida, Ken-ichi Aihara, Kiyoe Kurahashi, Yoshiaki Kuroda, Hideaki Horikawa, Eiji Tanaka, Masahiro Abe and Toshio Matsumoto :
A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration.,
Oncotarget, Vol.7, No.43, 70447-70461, 2016.
(Tokushima University Institutional Repository: 113048,   DOI: 10.18632/oncotarget.11927,   PubMed: 27626482)
9. MANSJUR KARIMA QURNIA, Shingo Kuroda, Takashi Izawa, Yuichi Maeda, Minami Sato, Keiichiro Watanabe, Shinya Horiuchi and Eiji Tanaka :
The Effectiveness of Human Parathyroid Hormone and Low-Intensity Pulsed Ultrasound on the Fracture Healing in Osteoporotic Bones.,
Annals of Biomedical Engineering, 2016.
(Tokushima University Institutional Repository: 109959,   DOI: 10.1007/s10439-015-1533-y,   PubMed: 26795976,   Elsevier: Scopus)
10. Takehiro Shinohara, Keiichiro Watanabe, Hiroki Mori, Takashi Izawa, Shinya Horiuchi, Shingo Kuroda, Kotaro Tanimoto and Eiji Tanaka :
顎関節内障を有する骨格性下顎前突症に対する矯正歯科治療の一治験例,
The Journal of Chu-Shikoku Orthodontic Society, Vol.27, No.1, 39-48, 2015.
11. Hirokazu Miki, Shingen Nakamura, A Oda, R Amachi, Keiichiro Watanabe, D Hanson, Jumpei Teramachi, Masahiro Hiasa, H Yagi, K Sogabe, M Takahashi, T Maruhashi, K Udaka, T Harada, Shiroh Fujii, A Nakano, Kumiko Kagawa, M Ri, S Iida, Shuji Ozaki, T Matsumoto and Masahiro Abe :
Induction of endoplasmic reticulum stress by bortezomib sensitizes myeloma cells to DR5-mediated cell death,
International Journal of Myeloma., Vol.5, No.1, 1-7, 2015.
12. Masahiro Hiasa, Jumpei Teramachi, A Oda, Ryota Amachi, T Harada, Shingen Nakamura, Hirokazu Miki, Shiroh Fujii, Kumiko Kagawa, Keiichiro Watanabe, Itsuro Endo, Y Kuroda, T Yoneda, Daisuke Tsuji, Michiyasu Nakao, Eiji Tanaka, Kenichi Hamada, Shigeki Sano, Kouji Itou, Toshio Matsumoto and Masahiro Abe :
Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma.,
Leukemia, 2014.
(DOI: 10.1038/leu.2014.147,   PubMed: 24787487)
13. Silvia Naomi Mitsui Akagi, Akihiro Yasue, Kiyoshi Masuda, Keiichiro Watanabe, Shinya Horiuchi, Issei Imoto and Eiji Tanaka :
Novel PAX9 Mutations Cause Non-syndromic Tooth Agenesis.,
Journal of Dental Research, Vol.93, No.3, 245-249, 2014.
(Tokushima University Institutional Repository: 109722,   DOI: 10.1177/0022034513519801,   PubMed: 24436340,   Elsevier: Scopus)
14. Yuichi Maeda, Akihiro Yasue, Ritsuko 徳永 律子 Oura, Silvia Naomi Mitsui Akagi, Tatsuya Nakamura, Keiichiro Watanabe, Takumi Takahashi and Eiji Tanaka :
Hypodontiaを伴う二卵性双生児の下顎後退症例,
The Journal of Chu-Shikoku Orthodontic Society, Vol.25, No.1, 43-50, 2013.
15. Shingen Nakamura, Hirokazu Miki, Shinsuke Kido, Ayako Nakano, Masahiro Hiasa, Asuka Oda, Hiroe Amou, Keiichiro Watanabe, Takeshi Harada, Shiroh Fujii, Kyoko Takeuchi, Kumiko Kagawa, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Activating transcription factor 4, an ER stress mediator, is required for, but exce ssive ER stress suppresses osteoblastogenesis by bortezomib.,
International Journal of Hematology, Vol.98, No.1, 66-73, 2013.
(Tokushima University Institutional Repository: 105938,   DOI: 10.1007/s12185-013-1367-z,   PubMed: 23708974,   Elsevier: Scopus)
16. Keiichiro Watanabe, Shingo Kuroda, Takumi Takahashi, Takeshi Kijima, Katsuyuki Torikai, Keiji Moriyama and Eiji Tanaka :
Segmental distraction osteogenesis with modified LeFort II osteotomy for a patient with craniosynostosis,
American Journal of Orthodontics and Dentofacial Orthopedics (AJO-DO), Vol.142, No.5, 698-709, 2012.
(DOI: 10.1016/j.ajodo.2012.07.007,   PubMed: 23116511)
17. Yuko Tomita, Shingo Kuroda, Tomoko Kataura, Teppei Watanabe, Keiichiro Watanabe, Shinji Fujihara and Eiji Tanaka :
Severity of alveolar cleft before palatoplasty affects vertical maxillofacial growth in 6-year-old patients with complete unilateral cleft lip and palate.,
American Journal of Orthodontics and Dentofacial Orthopedics (AJO-DO), Vol.141, No.4 Suppl, S102-9, 2012.
(DOI: 10.1016/j.ajodo.2011.09.010,   PubMed: 22449590,   Elsevier: Scopus)
18. Hirokazu Miki, Shingen Nakamura, Shuji Ozaki, A Oda, H Amou, Akishige Ikegame, Keiichiro Watanabe, Masahiro Hiasa, Q Cui, T Harada, Shiroh Fujii, A Nakano, Kumiko Kagawa, Kyoko Takeuchi, Ken-ichiro Yata, A Sakai, Masahiro Abe and Toshio Matsumoto :
KRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells and osteoclasts.,
British Journal of Haematology, Vol.155, No.3, 328-339, 2011.
(DOI: 10.1111/j.1365-2141.2011.08844.x,   PubMed: 21902681)
19. Shingo Kuroda, Keiichiro Watanabe, Kyoko Ishimoto, Hideki Nakanishi, Keiji Moriyama and Eiji Tanaka :
Long-term stability of LeFort III distraction osteogenesis with a rigid external distraction device in a patient with Crouzon syndrome.,
American Journal of Orthodontics and Dentofacial Orthopedics (AJO-DO), Vol.140, No.4, 550-561, 2011.
(DOI: 10.1016/j.ajodo.2009.12.038,   PubMed: 21967944)
20. Kazuna Takahara, Nobuhiko Kawai, Saika Nakamura, Kazuma Matsumoto, 天知 良太, Keiichiro Watanabe, Emi Kawakami, Ritsuko 徳永 律子 Oura, Kyoko Ishimoto, Shinji Fujihara, Shingo Kuroda and Eiji Tanaka :
徳島大学病院矯正歯科における患者の動向調査,
The Journal of Chu-Shikoku Orthodontic Society, Vol.23, No.1, 77-82, 2011.
21. Qu Cui, Hironobu Shibata, Asuka Oda, Hiroe Amou, Ayako Nakano, Kenichiro Yata, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Takeshi Harada, Shiroh Fujii, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Targeting myeloma-osteoclast interaction with V9V2 T cells.,
International Journal of Hematology, Vol.94, No.1, 63-70, 2011.
(DOI: 10.1007/s12185-011-0885-9,   PubMed: 21698356)
22. Kyoko Ishimoto, Shingo Kuroda, Takumi Takahashi, Keiichiro Watanabe and Eiji Tanaka :
ミニスクリュー固定を用いて上顎歯列の遠心移動を行ったアングルⅡ級2類過蓋咬合症例,
The Journal of Chu-Shikoku Orthodontic Society, Vol.21, No.1, 31-39, 2009.

Proceeding of International Conference:

1. J Ferraro, J Falter, S Lee, Keiichiro Watanabe, DG Kim and T Deguchi :
The Use of CBCT Derived Printed Models in Orthodontic Diagnosis.,
IADR 98th general session, Washington, D.C., Mar. 2020.
2. A Tsatalis, B Mitchell, Keiichiro Watanabe, T Deguchi and DG Kim :
Evaluation of the Necessity of CBCT During Placement of TADs.,
IADR 98th general session, Washington, D.C., Mar. 2020.
3. Y Huh, Keiichiro Watanabe and DG Kim :
Bone Mineral Density Distribution in Mandibular Incisors Region.,
IADR 98th general session, Washington, D.C., Mar. 2020.
4. Z Skabelund, Keiichiro Watanabe, S Lee, T Deguchi and DG Kim :
Sexual Dimorphism of Temporomandibular Joint Condyle Density Distribution.,
IADR 98th general session, Washington, D.C., Mar. 2020.
5. J Liu, Keiichiro Watanabe, ES Moon, Z Skabelund, SH Kim, SR Kim, D Lee, F Zheng, T Deguchi and DG Kim :
Sex dependent differences of oral bone mineral density.,
IADR 98th general session, Washington, D.C., Mar. 2020.
6. J Lamb, Keiichiro Watanabe, S Lee and DG Kim :
Tissue Mineral Density Distribution in Human Mandibular Premolar Region.,
IADR 98th general session, Washington, D.C., Mar. 2020.
7. SH Kim, Keiichiro Watanabe, SR Kim, Y Choi, T Deguchi and DG Kim :
Functional Demands Change Bone Mineral Density at Different Tooth Locations.,
IADR 98th general session, Washington, D.C., Mar. 2020.
8. Keiichiro Watanabe, S Lewis, A Ni, T Deguchi, B Lee and DG Kim :
Masticatory Effects On Regional Variation of Estrogen Deficient Rat Jaw Bone Density.,
Orthopaedic Research Society (ORS) 2020 Annual Meeting, Phoenix, Feb. 2020.
9. C Kiracofe, Keiichiro Watanabe, H Lee, J Liu, F Zheng and DG Kim :
Mastication diminishes effects of estrogen deficiceny on alveolar bone.,
IADR 97th general session, Vancouver, Jun. 2019.
10. T Ebrahimian, Keiichiro Watanabe, N Kim, AY Kim, F Zheng, J Liu and DG Kim :
Effects of osteoporosis therapeutic agents on oral trabecular bone.,
IADR 97th general session, Vancouver, Jun. 2019.
11. J Liu, Keiichiro Watanabe, ES Moon, Z Skabelund, SR Kim, D Lee, F Zheng, T Deguchi and DG Kim :
Effect of Aging on Oral Bone Mineral Density Distribution.,
IADR 97th general session, Vancouver, Jun. 2019.
12. Z Skabelund, Keiichiro Watanabe, S Lee, T Deguchi and DG Kim :
Sex Dependent Differences of Mandibular Condyle Density Distribution.,
IADR 97th general session, Vancouver, Jun. 2019.
13. E Sexton, P Kim, Keiichiro Watanabe, T Deguchi and DG Kim :
Relationships Between Male and Female Facial Morphological Measurements by CBCT.,
IADR 97th general session, Vancouver, Jun. 2019.
14. S Lewis, Keiichiro Watanabe, K Bodnyk, F Zheng and DG Kim :
Effects of Low Intensity Vibration on Oral Bone.,
IADR 97th general session, Vancouver, Jun. 2019.
15. H Zhang, DG Kim, B Foster, M Chavez, T Kolli, M Tan, H Fong, E Chu, Y Li, X Ren and Keiichiro Watanabe :
Dentoalveolar Defects in the Hyp Mouse Model of X-linked Hypophosphatemia.,
IADR 97th general session, Vancouver, Jun. 2019.
16. J Ferraro, J Falter, S Lee, Keiichiro Watanabe, DG Kim and T Deguchi :
Accuracy of 3-dimentional Printed Models from Intra-oral Scanner and CBCT.,
IADR 97th general session, Vancouver, Jun. 2019.
17. SR Kim, Keiichiro Watanabe, SH Kim, A Yousef, T Deguchi and DG Kim :
Alveolar Bone Quality Changes Depending on Masticatory Functional Demands.,
IADR 97th general session, Vancouver, Jun. 2019.
18. Keiichiro Watanabe, CM Han, A Tsatalis, D Lee, F Zheng, HM Kyung, T Deguchi and DG Kim :
Type-dependent Mechanical Stability of Orthodontic Miniscrew Implants.,
IADR 97th general session, Vancouver, Jun. 2019.
19. Hirofumi Tenshin, Jumpei Teramachi, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Toshio Matsumoto, Masahiro Abe and Eiji Tanaka :
Apoptosis inducer TRAIL stimulates osteoclast differentiation and survival via TAK1 activation.,
1st International Conference of Biophysical Technology in Dentistry (+10th International Scientific Meeting in Dentistry),, Makassar, Indonesia., Apr. 2018.
20. Hirofumi Tenshin, Jumpei Teramachi, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Toshio Matsumoto, Masahiro Abe and Eiji Tanaka :
Apoptosis inducer TRAIL stimulates osteoclast differentiation and survival via TAK1 activation.,
The 4th ASEAN plus Tokushima Joint International Conference, Bali, Indonesia, Dec. 2017.
21. Hirofumi Tenshin, Jumpei Teramachi, A Oda, Ryota Amachi, Masahiro Hiasa, A Baterdene, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Osteoclasts utilize TRAIL for their NF-B activation, but TAK1 inhibition resumes TRAIL-induced apoptosis in osteoclasts.,
Australian and New Zealand Bone and Mineral Society 2017, Brisbane, Australia., Jun. 2017.
22. Ryota Amachi, Masahiro Hiasa, Oda Asuka, Bat-Erdene Ariunzaya, Jumpei Teramachi, Hirofumi Tenshin, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shiroh Fujii, Toshio Matsumoto, Eiji Tanaka and Masahiro Abe :
Osteoblast Creates a Non-permissive Niche for Myeloma Cells,
95th General Session & Exhibition of the IADR program book, San Francisco, Mar. 2017.
23. Hirofumi Tenshin, Jumpei Teramachi, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Toshio Matsumoto, Masahiro Abe and Eiji Tanaka :
TRAIL Stimulates Osteoclast Differentiation and Survival via TAK1 Activation.,
95th General Session & Exhibition of the IADR program book, San Francisco, Mar. 2017.
24. Hirofumi Tenshin, Jumpei Teramachi, A Oda, Ryota Amachi, Bingzi Dong, Masahiro Hiasa, Keiichiro Watanabe, Ryota Amachi, S Nakamura, H Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Osteoclasts utilize an apoptosis-inducer TRAIL as a stimulator for osteoclastogenesis Critical roles of the TAK-1-Pim-2 signaling induced by RANK ligand and TRAIL.,
ANZBMS 2016 Annual Meeting, Gold Coast, Aug. 2016.
25. Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Derek Hanson, Keiichiro Watanabe, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Pim inhibition suppresses osteoclastogenesis and tumor growth in myeloma,
57th ASH Annual Meeting and Exposition, Orlando, Dec. 2015.
26. Hirofumi Tenshin, Jumpei Teramachi, A Oda, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, S Nakamura, H Miki, I Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TRAIL is not a proapoptotic but rather anti-apoptotic mediator for osteoclasts to stimulate their differentiation and survival,
ASBMR 2015 Annual Meeting, Seattle, Oct. 2015.
27. Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, Asuka Oda, Hirofumi Tenshin, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shiroh Fujii, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Up-regulation of the pH sensor TRPV1 in myeloma cells and their adaption to an acidic microenvironment,
ASBMR 2015 Annual Meeting, Seattle, Oct. 2015.
28. Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Keiichiro Watanabe, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Pivotal role of TAK-1 in tumor growth and bone destruction in myeloma: Therapeutic impact of TAK-1 inhibition,
American Society for Bone and Mineral Research 2015 Annual Meeting, Oct. 2015.
29. Hirokazu Miki, Shingen Nakamura, Hirofumi Tenshin, Ryota Amachi, Keiichiro Watanabe, Jumpei Teramachi, Shiroh Fujii, Kumiko Kagawa and Masahiro Abe :
Effective impairment of myeloma progenitors by hyperthermia: augmentation with bortezomib and Pim inhibition in combination,
Clinical Lymphoma, Myeloma & Leukemia, Vol.15, No.S3, e217-e218, Sep. 2015.
(DOI: 10.1016/j.clml.2015.07.470)
30. Shingen Nakamura, Hirokazu Miki, Hirofumi Tenshin, Ryota Amachi, Keiichiro Watanabe, Jumpei Teramachi, Shiroh Fujii, Kumiko Kagawa and Masahiro Abe :
Alteration of Pim-2 expression by clinically available anti-myeloma agents: combinatory anti-myeloma effects with Pim inhibition,
Clinical Lymphoma, Myeloma & Leukemia, Vol.15, No.S3, e243, Sep. 2015.
(DOI: 10.1016/j.clml.2015.07.517)
31. Silvia Naomi Mitsui Akagi, Akihiro Yasue, K Matsuda, Keiichiro Watanabe, Shinya Horiuchi, Issei Imoto and Eiji Tanaka :
Sequence analysis and in vitro study of novel mutations identified in patients with tooth agenesis,
The 3rd ASEAN Plus and Tokushima Joint International Conference, Makassar, Indonesia., Dec. 2014.
32. Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, Ryota Amachi, Takeshi Harada, Shingen Nakamura, Kumiko Kagawa, Hirokazu Miki, Shiroh Fujii, Keiichiro Watanabe, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Critical role of Pim-2 in NF-B-mediated suppression of osteoblastogenesis and stimulation of osteoclastogenesis: Therapeutic impact of Pim inhibition on myeloma bone disease.,
2014 ASBMR Annual Meeting, Houston, Sep. 2014.
33. Ryota Amachi, Masahiro Abe, Masahiro Hiasa, Keiichiro Watanabe, S Fujii, T Harada, H Miki, S Nakamura, I Endo, Eiji Tanaka and Toshio Matsumoto :
Acidic conditions epigenetically repress the TRAIL receptor DR4 in myeloma cells to confer their resistance to TRAIL,
ASBMR 2013 Annual Meeting,, Baltimore, Oct. 2013.
34. Keiichiro Watanabe, Masahiro Abe, H Mori, Ryota Amachi, Masahiro Hiasa, T Harada, S Fujii, S Nakamura, H Miki, K Kagawa, I Endo, Eiji Tanaka and Toshio Matsumoto :
Potent induction of bone formation in myeloma bone lesions by the cathepsin K inhibitor KK1-300-01 in combination with the proteasome inhibitor bortezomib,
ASBMR 2013 Annual Meeting,, Baltimore, Oct. 2013.
35. Keiichiro Watanabe, Masahiro Abe, Ryota Amachi, Masahiro Hiasa, T Harada, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, H Mori, Itsuro Endo, Eiji Tanaka and Toshio Matsumoto :
Induction of bone formation in myeloma osteolytic lesions by cathepsinK inhibition,
Kyoto, Apr. 2013.
36. Ryota Amachi, Keiichiro Watanabe, Shiroh Fujii, T Harada, Hirokazu Miki, Shingen Nakamura, A Oda, Masahiro Hiasa, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
An acidic milieu suppersses histone acetylation in myeloma cells to down-regulate the TRAIL receptor DR4 expression.,
Kyoto, Apr. 2013.
37. Ryota Amachi, Masahiro Abe, Ryota Amachi, Keiichiro Watanabe, S Fujii, T Harada, H Miki, S Nakamura, A Oda, Masahiro Hiasa, Eiji Tanaka and Toshio Matsumoto :
An acidic milieu suppresses DR4 editing to cause myeloma resistance to TRAIL,
ASEAN plus and Tokushima Joint International Conference, Yogjakarta, Indonesia, Dec. 2012.
38. Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Harada Takeshi, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition,
12th Int'l Meeting on Cancer Induced Bone Disease, Lyon, Nov. 2012.
39. Masahiro Hiasa, Ryota Amachi, Keiichiro Watanabe, Harada Takeshi, Fujii Shirou, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Itsuro Endo, Toshio Matsumoto and Masahiro Abe :
Pim-2 suppresses BMP-2 signaling as a common inhibitory mediator of osteoblastogenesis in myeloma,
ASBMR 2012 Anuual Meeting, Minneapolis, Oct. 2012.
40. Keiichiro Watanabe, Masahiro Abe, Ryota Amachi, Masahiro Hiasa, T Harada, S Fujii, S Nakamura, H Miki, K Kagawa, H Mori, I Endo, Eiji Tanaka and Toshio Matsumoto :
Restoration of bone formation in myeloma osteolytic lesions by the cathepsin K inhibitor KK1-300-01,
34th ASBMR meeting, Minneapolis, MN, USA., Oct. 2012.
41. Keiichiro Watanabe, Masahiro Abe, Hiroyo Mori, Ryota Amachi, Masahiro Hiasa, T Harada, S Fujii, S Nakamura, H Miki, K Kagawa, I Endo, Eiji Tanaka and Toshio Matsumoto :
The cathepsin K inhibitor KK1-300-01 prevents bone destruction and resumes bone formation in myeloma osteolytic lesions,
Australian & New Zealand Bone & Mineral Society 22th Annual Scientific Meeting with 1st Asia-Pacific Bone and Mineral Research meeting, Perth, Australia., Sep. 2012.
42. Keiichiro Watanabe, Masahiro Abe, M Kawatani, Masahiro Hiasa, A Kawano, T Jinno, T Harada, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Eiji Tanaka, H Osada and Toshio Matsumoto :
Aggravation of myeloma growth and drug resistance by an acidic created in myeloma-osteoclast interaction.,
ASBMR 2011 Annual Meeting, San Diego, Sep. 2011.
43. Masahiro Hiasa, nakano ayako, Keiichiro Watanabe, C Qu, T Harada, Shiroh Fujii, Hirokazu Miki, Shingen Nakamura, Kumiko Kagawa, Kyoko Takeuchi, Eiji Tanaka, Kenzo Asaoka, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition.,
ASBMR 2011 Annual Meeting, San Diego, Sep. 2011.
44. Masahiro Hiasa, nakano ayako, Keiichiro Watanabe, C Qu, T Harada, Shiroh Fujii, Hirokazu Miki, Shingen Nakamura, Kumiko Kagawa, Kyoko Takeuchi, Eiji Tanaka, Kenzo Asaoka, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Dual effects of Pim inhibition on myeloma: induction of bone formation and tumor suppression.,
IOF-ANZBMS 2011 Annual Meeting, Gold Coast, Sep. 2011.
45. Keiichiro Watanabe, Masahiro Abe, Cui Qu, Kawatani Makoto, Masahiro Hiasa, Nakano Ayako, Jinno Tadashi, Harada Takeshi, Shiroh Fujii, Shingen Nakamura, Miki Hirokazu, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Eiji Tanaka, Osada Hiroyuki and Toshio Matsumoto :
An Acidic Mileu Created In Myeloma-Osteoclast Interaction Enhances Tumor Growth, but Triggers Anti-Myeloma Activity of Reveromycin A, a Novel Anti-Resorptive Agent,
52th American Society of Hematology, Orlando, Dec. 2010.
46. Cui Qu, Masahiro Abe, Miki Hirokazu, Shingen Nakamura, Keiichiro Watanabe, Akishige Ikegame, Masahiro Hiasa, Nakano Ayako, Harada Takeshi, Shiroh Fujii, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki and Toshio Matsumoto :
Lenalidomide In Combination with Zoledronic Acid Restores the Activation and Anti-Myeloma Effects of γδT Cells Attenuated by the Bone Marrow Microenvironment,
52th American Society of Hematology, Orlando, Dec. 2010.
47. Keiichiro Watanabe, Masahiro Abe, Cui Qu, Kawatani Makoto, Masahiro Hiasa, Nakano Ayako, Jinno Tadashi, Harada Takeshi, Shiroh Fujii, Shingen Nakamura, Miki Hirokazu, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Eiji Tanaka, Osada Hiroyuki and Toshio Matsumoto :
A Novel Anti-resorptive Agent, Reveromycin A, Ameliorates Bone Destruction and Tumor Growth in Myeloma,
ASBMR 2010 Annual Meeting, Toronto, Oct. 2010.
48. Masahiro Hiasa, Masahiro Abe, nakano ayako, oda aska, amo hiroe, Keiichiro Watanabe, Shingen Nakamura, miki hirokazu, Kyoko Takeuchi, Kumiko Kagawa, Shuji Ozaki, Eiji Tanaka, Kenzo Asaoka and Toshio Matsumoto :
Bone Marrow Stromal Cells Suppress TACE-mediated M-CSFR and RANK Shedding to Facilitate Osteoclastogenesis and Suppress DC Differentiation from Monocytes.,
ASBMR 2010 Annual Meeting, Toronto, Oct. 2010.
49. Masahiro Abe, Masahiro Hiasa, Nakano A, Shingen Nakamura, Miki H, Qu C, Keiichiro Watanabe, Harada T, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki and Toshio Matsumoto :
TIMP-3 up-regulation facilitates osteoclastogenesis and suppresses DC differentiation from monocytes in the bone marrow microenvironment in myeloma,
10th International Conference Cancer-induced Bone Disease, Sep. 2010.
50. Keiichiro Watanabe, Masahiro Abe, Cui Qu, Kawatani Makoto, Masahiro Hiasa, Nakano Ayako, Jinno Tadashi, Harada Takeshi, Shiroh Fujii, Shingen Nakamura, Miki Hirokazu, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Eiji Tanaka, Osada Hiroyuki and Toshio Matsumoto :
The novel anti-resorptive agent reveromycin A ameliorates bone destruction and tumor growth in myeloma,
10th International Conference Cancer-induced Bone Disease, Sheffield (United Kingdom), Sep. 2010.

Proceeding of Domestic Conference:

1. Masahiro Hiasa, Masahiro Abe, 中野 綾子, Keiichiro Watanabe, Shingen Nakamura, Eiji Tanaka, Kenzo Asaoka and Toshio Matsumoto :
Pimキナーゼの阻害は骨芽細胞分化を促進し,骨髄腫骨病変の形成と腫瘍進展を抑制する,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 178,
2. Keiichiro Watanabe, Masahiro Abe, 川谷 誠, Masahiro Hiasa, Shingen Nakamura, Eiji Tanaka, 長田 裕之 and Toshio Matsumoto :
リベロマイシンAによる酸性環境がもたらす骨髄腫薬剤耐性の克服と骨病変形成の抑制,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 208,
3. Keiichiro Watanabe, Eiji Tanaka and 出口 徹 :
口腔内スキャナーおよびCBCT画像を組み合わせた3次元歯科模型の開発,
第78回日本矯正歯科学会学術大会: 日本矯正歯科学会大会プログラム・抄録集 78回 Page206.(2019), 206, Nov. 2019.
4. T Deguchi, J Ferraro, J Falter, S Lee, Keiichiro Watanabe and DG Kim :
Accuracy of 3-dimentional printed models from intra-oral scanner and CBCT.,
第78回日本矯正歯科学会学術大会, Nov. 2019.
5. 森 仁志, Hiroki Mori, 塩屋園 玲子, Keiichiro Watanabe, Shinya Horiuchi, 菅野 貴浩 and Eiji Tanaka :
閉塞性睡眠時無呼吸症候群を伴うPierre Robin Sequenceに対し下顎骨前方移動術を行った1例,
第62回中・四国矯正歯科学会大会, Vol.31, No.1, Jul. 2019.
6. 清水 宗, Shinya Horiuchi, Hirofumi Tenshin, Akihiko Iwasa, Keiichiro Watanabe, Masahiro Hiasa, Tsutomu Iwamoto and Eiji Tanaka :
徳島大学病院矯正歯科における口唇裂・口蓋裂患者の合併先天異常に関する実態調査.,
第43回日本口蓋裂学会総会・学術大会, May 2019.
7. Soh Shimizu, Shinya Horiuchi, Hirofumi Tenshin, Akihiko Iwasa, Keiichiro Watanabe, Masahiro Hiasa, Tsutomu Iwamoto and Eiji Tanaka :
徳島大学病院矯正歯科における口唇裂・口蓋裂患者の合併先天異常に関する実態調査.,
Journal fo Japanese Cleft Palate Association, May 2019.
8. 森 仁志, Hiroki Mori, 塩屋園 玲子, Keiichiro Watanabe, Shinya Horiuchi and Eiji Tanaka :
上顎中切歯の翼状捻転を伴う叢生症例,
第61回中・四国矯正歯科学会大会, Vol.30, No.1, 77-78, Jul. 2018.
9. Akihiko Iwasa, Haruna Konishi, Kana Fujimoto, Naoko Ogasawara, Keiichiro Watanabe, Masahiro Hiasa, Shinya Horiuchi and Eiji Tanaka :
徳島大学病院矯正歯科患者における永久歯埋伏に関する臨床統計学的調査,
第76回日本矯正歯科学会学術大会, Oct. 2017.
10. Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Ariunzaya Baterdene, Masami Iwasa, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TRAILは破骨細胞を活性化させるが,TAK1阻害により骨髄腫細胞とともに破骨細胞にもTRAILのアポトーシス誘導活性が惹起できる,
The 35th Annual Meeting of the Japanese Society for Bone and Mineral Research (oral talk), Jul. 2017.
11. 森 仁志, Hiroki Mori, 塩屋園 玲子, Keiichiro Watanabe, Shinya Horiuchi and Eiji Tanaka :
ペンデュラムアプライアンスを使用して上顎第一大臼歯を遠心移動した3症例,
第60回中・四国矯正歯科学会大会, Jul. 2017.
12. Kana Fujimoto, Haruna Konishi, Akihiko Iwasa, Aki Ichihara, Manami Shirai, Keiichiro Watanabe, Masahiro Hiasa, Hiroyo Mori, Shinya Horiuchi and Eiji Tanaka :
歯科矯正患者における埋伏永久歯に関する実態調査,
第60回中・四国矯正歯科学会大会, Jul. 2017.
13. Daishi Arai, Keiichiro Watanabe, Islamy Rahma Hutami, Hirofumi Tenshin, Takehiro Shinohara, Nao Kinouchi and Eiji Tanaka :
矯正歯科患者における近年の永久前歯歯冠幅径の変化,
第60回中・四国矯正歯科学会大会 学術口演, Jul. 2017.
14. Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Baterdene Ariunzaya, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TAK1阻害はTRAILの抗骨髄腫作用を増強するともに骨吸収促進活性を抑制活性に変換する.,
第42回日本骨髄腫学会, May 2017.
15. 天知 良太, Shingen Nakamura, Masahiro Hiasa, 小田 明日香, バットエルデネ アリウンザヤ, Jumpei Teramachi, Hirofumi Tenshin, Keiichiro Watanabe, Hirokazu Miki, Kumiko Kagawa, Shiroh Fujii, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
骨形成誘導による骨髄腫細胞のエネルギー代謝の抑制,
第42回日本骨髄腫学会学術集会, May 2017.
16. Haruna Konishi, Kana Fujimoto, Akihiko Iwasa, Keiichiro Watanabe, Shinya Horiuchi and Eiji Tanaka :
不正咬合患者における埋伏歯についての臨床統計学的調査,
四国歯学会第50回例会, Mar. 2017.
17. Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
30. 天真寛文, 寺町順平, 小田明日香, 天知良太, , ,破骨細胞系細胞はアポトーシス誘引因子TRAILを生存促進・破骨細胞形成誘導因子として利用する:TAK1-Pim-2経路の役割,
第19回日本癌と骨病変研究会, Nov. 2016.
18. Hirofumi Tenshin, Keiichiro Watanabe, Manami Shirai, Natsuko Hichijo and Eiji Tanaka :
新たな下顎臼歯の遠心移動量および移動様式の予測指標の開発-第2報-,
日本矯正歯科学会大会プログラム・抄録集. 第75回大会, Nov. 2016.
19. Keiichiro Watanabe, Hirofumi Tenshin, Manami Shirai, Natsuko Hichijo and Eiji Tanaka :
新たな下顎臼歯の遠心移動量および移動様式の予測指標の開発-第1報-,
日本矯正歯科学会大会プログラム・抄録集. 第75回大会, Nov. 2016.
20. 森 仁志, Hiroki Mori, Takehiro Shinohara, Ryota Amachi, 塩屋園 玲子, Keiichiro Watanabe, Shinya Horiuchi, 菅野 貴浩 and Eiji Tanaka :
比較的大きな顎裂を有する口唇口蓋裂患者に対する骨トランスポート骨延長法の応用,
日本矯正歯科学会大会プログラム・抄録集., 263., Nov. 2016.
21. Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TAK1 inhibition subverts TRAIL-mediated osteoclastogenesis.,
第77回日本血液学会学術集会,, Oct. 2016.
22. Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, 小田 明日香, Hirofumi Tenshin, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shiroh Fujii, 遠藤 逸郎, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Mechanism of the TRPV1 up-regulatation in myeloma cells and adaptation to an acidic microenvironment.,
第77回日本血液学会学術集会,, Oct. 2016.
23. Keiichiro Watanabe, Jumpei Teramachi, Ryota Amachi, 小田 明日香, Hirofumi Tenshin, 岩浅 正美, Masahiro Hiasa, Shingen Nakamura, 遠藤 逸郎, 川谷 誠, 長田 裕之, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Amelotin gene expression is temporarily being upregulated at the initiation of apoptosis induced by TGFb1 in mouse gingival epithelial cells,
第77回日本血液学会学術集会,, Oct. 2016.
24. 黒田 優子, Shinya Horiuchi, Keiichiro Watanabe, Akihiro Yasue and Eiji Tanaka :
口唇裂口蓋裂児の裂型は幼児期における上顎歯槽部の垂直的な成長に影響を及ぼす,
The Journal of Chu-Shikoku Orthodontic Society, Vol.28, No.(1), 127, Aug. 2016.
25. Keiichiro Watanabe, Jumpei Teramachi, Ryota Amachi, 小田 明日香, Hirofumi Tenshin, Masahiro Hiasa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, 川谷 誠, 長田 裕之, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
リベロマイシンAによる酸性環境での骨髄腫細胞の治療抵抗性の克服,
日本骨代謝学会学術集会プログラム抄録集 (1349-0761)34回 Page183(2016.07), 183, Jul. 2016.
26. Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
破骨細胞はTAK1の発現誘導を介しアポトーシスを抑制しTRAILにより成熟活性化される,
日本骨代謝学会学術集会プログラム抄録集 (1349-0761)34回 Page183(2016.07), 183, Jul. 2016.
27. Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, Hirofumi Tenshin, Ryota Amachi, 原田 武志, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
骨髄腫腫瘍進展と骨破壊病変形成におけるTAK1-Pim-2経路の役割,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, Jul. 2016.
28. Jumpei Teramachi, Masahiro Hiasa, 小田 明日香, 原田 武志, Hirofumi Tenshin, Shingen Nakamura, Ryota Amachi, Shiroh Fujii, Keiichiro Watanabe, Kumiko Kagawa, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Pim-2は骨髄腫における破骨細胞形成促進の 必須媒介因子である,
第41回日本骨髄腫学会学術集会, May 2016.
29. Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TRAILは破骨細胞に細胞死を誘導せず,破骨細胞分化・生存を促進する.,
第41回日本骨髄腫学会, May 2016.
30. MANSJUR KARIMA QURNIA, Shingo Kuroda, Yuichi Maeda, Minami Sato, Silvia Naomi Mitsui Akagi, ODO BAYARSAIKHAN, Keiichiro Watanabe and Eiji Tanaka :
Applications of parathyroid hormone and low intensity pulsed ultrasound enhance fracture healing in osteoporotic rats,
第74回日本矯正歯科学会大会プログラム・抄録集, 142, Nov. 2015.
31. Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, A Oda, Hirofumi Tenshin, Keiichiro Watanabe, Shingen Nakamura, H Miki, Kumiko Kagawa, Shiroh Fujii, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Mechanism of the TRPV1 up-regulatation in myeloma cells and adaptation to an acidic microenvironment,
第77回日本血液学会学術集会, Oct. 2015.
32. Keiichiro Watanabe, Jumpei Teramachi, H Mori, Y Ochi, Ryota Amachi, A Oda, Masahiro Hiasa, T Harada, Shiroh Fujii, Shingen Nakamura, H Miki, Kumiko Kagawa, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
Potent induction of bone formation by anti-resorptive cathepsin K inhibitor in myeloma,
第77回日本血液学会学術集会, Oct. 2015.
33. Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Keiichiro Watanabe, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Potent suppression of osteoclastogenesis in myeloma by Pim inhibition,
第77回日本血液学会学術集会, Oct. 2015.
34. Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Keiichiro Watanabe, Shiroh Fujii, Kumiko Kagawa, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto and Masahiro Abe :
Tumor reduction and bone restoration in myeloma by TAK-1 inhibition,
第77回日本血液学会学術集会, Oct. 2015.
35. Kaoru Yoshinaga, Keiichiro Watanabe, Ruri Nakamura, Minami Sato, Silvia Naomi Mitsui Akagi, Ryota Amachi, Akihiko Iwasa, Shinya Horiuchi, Shingo Kuroda and Eiji Tanaka :
歯科矯正用アンカースクリューの導入による診断内容の変化∼抜歯・非抜歯および抜歯部位の判定に関する検討∼,
第58回中·四国矯正歯科学会大会, 18, Jul. 2015.
36. Hirofumi Tenshin, Keiichiro Watanabe, Natsuko Hichijo, Akiko Mino, Hiroki Mori, MANSJUR KARIMA QURNIA, Akihiro Yasue, Shingo Kuroda and Eiji Tanaka :
歯科矯正用アンカースクリューを用いた下顎臼歯遠心移動量および移動様式の治療前予測に関する検討,
第58回中·四国矯正歯科学会大会, 14, Jul. 2015.
37. Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
TRAILは破骨細胞分化・生存を促進する:TAK-1による生と死の運命制御,
第1回日本骨免疫学会, 137, Jul. 2015.
38. Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, 小田 明日香, Hirofumi Tenshin, Keiichiro Watanabe, Shingen Nakamura, Kumiko Kagawa, Hirokazu Miki, Shiroh Fujii, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
酸環境での骨髄腫細胞のDR4発現抑制:酸によるエピジェネティックな遺伝子発現制御,
第1回日本骨免疫学会, 108, Jul. 2015.
39. Ryota Amachi, Masahiro Hiasa, Jumpei Teramachi, 小田 明日香, Keiichiro Watanabe, Hirofumi Tenshin, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Takeshi Kondo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
酸性環境での骨髄腫細胞のTRPV1の発現亢進と酸環境への適応,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 165, Jul. 2015.
40. Hirofumi Tenshin, Jumpei Teramachi, 小田 明日香, Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Shingen Nakamura, Hirokazu Miki, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
アポトーシス誘導因子TRAILによる破骨細胞分化・生存の促進,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 164, Jul. 2015.
41. Kazuna Takahara, Shinya Horiuchi, Keiichiro Watanabe, Shingo Kuroda, Ichiro Hashimoto and Eiji Tanaka :
顎裂部唇側に腸骨海綿骨移植術を施行した両側性唇顎口蓋裂症例,
日本口蓋裂学会雑誌抄録号(39回総会・学術集会), Vol.40, No.2, 161, May 2015.
42. MANSJUR KARIMA QURNIA, Shingo Kuroda, Minami Sato, KHALIUNAA GANZORIG, Yuichi Maeda, Keiichiro Watanabe, Shinya Horiuchi and Eiji Tanaka :
Effectiveness of low-intensity pulsed ultrasound for the treatment of tibial fractures in osteoporotic rats,
第73回日本矯正歯科学会大会・第5回日韓ジョイントミーティング プログラム・抄録集, 350, Oct. 2014.
43. Ryota Amachi, Masahiro Hiasa, Keiichiro Watanabe, Jumpei Teramachi, 小田 明日香, Keiichiro Watanabe, Shingen Nakamura, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
酸が惹起する骨髄腫細胞の酸感受と生存シグナルの悪循環,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 225, Jul. 2014.
44. Takehiro Shinohara, Keiichiro Watanabe, Hiroki Mori, Takashi Izawa, Shinya Horiuchi, Shingo Kuroda and Eiji Tanaka :
顎関節内障を有する骨格性下顎前突症に対する矯正歯科治療の一治験例,
第57回中·四国矯正歯科学会大会, 21, Jul. 2014.
45. Takehiro Shinohara, Keiichiro Watanabe, Akiko Mino, Naoko Yoneda, Kazuna Takahara, Akihiro Yasue, Shinya Horiuchi, Shingo Kuroda and Eiji Tanaka :
口唇裂・口蓋裂患者における歯科矯正治療の実態調査,
第38回日本口蓋裂学会総会・学術集会, May 2014.
46. Keiichiro Watanabe, Masahiro Abe, H Mori, K Udaka, M Iwasa, D Hanson, Ryota Amachi, Masahiro Hiasa, T Harada, Shiroh Fujii, Shingen Nakamura, H Miki, Kumiko Kagawa, Itsuro Endo, Eiji Tanaka and Toshio Matsumoto :
Bone restoration and tumor suppression in myeloma by cathepsin K inhibition with Bortezomib,
第75回日本血液学会学術集会, Oct. 2013.
47. Ryota Amachi, Keiichiro Watanabe, Masahiro Hiasa, Masahiro Abe, Toshio Matsumoto and Eiji Tanaka :
酸性環境が骨髄腫細胞の破骨細胞活性に及ぼす影響,
第72回日本矯正歯科学会大会プログラム・抄録集, Oct. 2013.
48. Masahide Inoue, Shingo Kuroda, Keiichiro Watanabe, Natsuko Hichijo, 荒古江 圭嗣, 上田 寛治 and Eiji Tanaka :
歯科矯正用アンカースクリューの直径,埋入角度および荷重方向の違いが周囲骨組織内応力分布へ及ぼす影響,
第72回日本矯正歯科学会大会プログラム・抄録集, Oct. 2013.
49. Keiichiro Watanabe, Shingo Kuroda, Hiroki Mori and Eiji Tanaka :
歯科矯正用アンカースクリューを用いて治療した成長期の骨格性II級前歯部開咬症例,
第72回日本矯正歯科学会大会プログラム・抄録集, Oct. 2013.
50. Hiroki Mori, Keiichiro Watanabe, Ryoko Uchida, Takashi Izawa, Shingo Kuroda, 森 仁志 and Eiji Tanaka :
圧迫骨短縮術を施術した,エナメル質形成不全を伴う骨格性開咬の一治療例,
第56回中·四国矯正歯科学会大会, Jul. 2013.
51. Ryota Amachi, Keiichiro Watanabe, Shiroh Fujii, T Harada, H Miki, S Nakamura, A Oda, Masahiro Hiasa, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
An acdic milieu confers the resistance to TRAIL in myeloma cells through the PI3K-Akt-mediated epigenetic down-regulation of the TRAIL receptor DR4,
International Bone and Mineral Society 2013, May 2013.
52. Keiichiro Watanabe, Masahiro Abe, H Mori, Ryota Amachi, Masahiro Hiasa, T Harada, Shiroh Fujii, S Nakamura, H Miki, K Kagawa, I Endo, Eiji Tanaka and Toshio Matsumoto :
Induction of cathepsin K induce bone formation in myeloma osteolytic lesions,
International Bone and Mineral Society 2013, May 2013.
53. Ryota Amachi, Keiichiro Watanabe, Shiroh Fujii, T Harada, H Miki, S Nakamura, A Oda, Masahiro Hiasa, Eiji Tanaka, Toshio Matsumoto and Masahiro Abe :
An acdic milieu suppresses histone acetylation in myeloma cells to down-regulate the TRAIL receptor DR4 expression,
14th International Myeloma Workshop, Apr. 2013.
54. Keiichiro Watanabe, Masahiro Abe, Ryota Amachi, Masahiro Hiasa, T Harada, Shiroh Fujii, S Nakamura, H Miki, K Kagawa, I Endo, Eiji Tanaka and Toshio Matsumoto :
Induction of bone formation in myeloma osteolytic lesions by cathepsin K inhibition,
14th International Myeloma Workshop, Apr. 2013.
55. Silvia Naomi Mitsui Akagi, Akihiro Yasue, Keiichiro Watanabe, Shinya Horiuchi and Eiji Tanaka :
Candidate gene analysis in patients with tooth agenesis,
第60回国際歯科研究学会日本部会総会・学術大会, Dec. 2012.
56. Naoki Abe, Keiichiro Watanabe, Shingo Kuroda and Eiji Tanaka :
顔認証システムを用いた顎矯正手術後の顔貌予測システムの開発,
第30回日本頭蓋顎顔面外科学会学術大会, Nov. 2012.
57. Keiichiro Watanabe, Shingo Kuroda, Hideki Nakanishi and Eiji Tanaka :
機能的矯正装置による顎整形的治療を行ったHemifacial microsomiaの長期観察例,
第30回日本頭蓋顎顔面外科学会学術大会, Nov. 2012.
58. Shiroh Fujii, Masahiro Abe, Ryota Amachi, Keiichiro Watanabe, Masahiro Hiasa, 竹内 恭子, 岩佐 昌美, 原田 武志, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa and Toshio Matsumoto :
Pim inhibition preferentially induces anti-myeloma activity in an acidic milien,
第74回日本血液学会学術集会, Oct. 2012.
59. Masahiro Hiasa, Masahiro Abe, Kumiko Kagawa, Hirokazu Miki, Shingen Nakamura, Harada Takeshi, Fujii Shirou, Keiichiro Watanabe, Ryota Amachi, Kenzo Asaoka and Toshio Matsumoto :
Pim-2 acts as a common downstream mediator to suppress bone formation in myeloma.,
第74回に本血液学会, Oct. 2012.
60. Ryota Amachi, Masahiro Abe, Keiichiro Watanabe, Masahiro Hiasa, Eiji Tanaka and Toshio Matsumoto :
An acidic milieu suppresses DR4 editing and induces p22 c-FLIP to cause myeloma resistance to TRAIL,
第74回日本血液学会学術集会, Oct. 2012.
61. Silvia Naomi Mitsui Akagi, Akihiro Yasue, Keiichiro Watanabe, Teppei Watanabe, Naoko Yoneda, Shinya Horiuchi and Eiji Tanaka :
Msx1 gene analysis in non-syndromic tooth agenesis,
第71回日本矯正歯科学会大会プログラム・抄録集, 301, Sep. 2012.
62. Masahide Inoue, Shingo Kuroda, Keiichiro Watanabe, Kazuna Takahara, Hiroyo Mori and Eiji Tanaka :
Influences of insertion torque in success rate of miniscrews,
第71回日本矯正歯科学会大会プログラム・抄録集, 213, Sep. 2012.
63. Keiichiro Watanabe, Masahiro Abe, Ryota Amachi, Masahiro Hiasa, Shingen Nakamura, 遠藤 逸郎, 森 裕史, Eiji Tanaka and Toshio Matsumoto :
カテプシンK 阻害剤KK1-300-01 は骨髄腫骨病変部の骨破壊を抑制し骨形成を惹起する,
第30回日本骨代謝学会学術大会, 217, Jul. 2012.
64. Ryota Amachi, Masahiro Abe, Keiichiro Watanabe, Shingen Nakamura, Masahiro Hiasa, Eiji Tanaka and Toshio Matsumoto :
酸性環境は骨髄腫細胞にDR4 の発現抑制とcFLIP の活性化を惹起しTRAIL に対する抵抗性を獲得させる,
第30回日本骨代謝学会学術集会, 259, Jul. 2012.
65. 森 仁志, Keiichiro Watanabe, Ryoko Uchida, Shinya Horiuchi and Eiji Tanaka :
Skeletal stability after maxillary advancement using a semi custom-made internal distraction debvice in cleft lip and palate patients,
第55回中・四国矯正歯科学会大会, 41, Jul. 2012.
66. Yuichi Maeda, Akihiro Yasue, Ritsuko 徳永 律子 Oura, Tatsuya Nakamura, Keiichiro Watanabe and Eiji Tanaka :
Maxillary protrusion cases of dizygotic twins with hypodontia,
第55回中・四国矯正歯科学会大会, 24, Jul. 2012.
67. Keiichiro Watanabe, Masahiro Abe, Q Cui, Masahiro Hiasa, M Kawatani, T Harada, Shiroh Fujii, Shingen Nakamura, Hirokazu Miki, A Nakano, K Kagawa, K Takeuchi, H Osada, Eiji Tanaka and Toshio Matsumoto :
Targeting an acidic microenvironment by reveromycin A to overcome drug resistance to myeloma cells and ameliorate bone disease.,
第36回日本骨髄腫研究会総会, Nov. 2011.
68. Shinya Horiuchi, Shingo Kuroda, Masahiro Hiasa, Ryota Amachi, Keiichiro Watanabe, Emi Kawakami, Nobuhiko Kawai and Eiji Tanaka :
S-PRGフィラー含有矯正歯科用接着剤の歯質脱灰抑制効果に関する検討,
日本矯正歯科学会大会プログラム・抄録集, 312, Oct. 2011.
69. Masahiro Hiasa, A Nakano, Keiichiro Watanabe, C Qu, T Harada, S Fujii, H Miki, S Nakamura, K Kagawa, K Takeuchi, Eiji Tanaka, Kenzo Asaoka, Shuji Ozaki, Toshio Matsumoto and Masahiro Abe :
Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition,
Bone Biology Forum, 19-21st Aug, 2011, Shizuoka., Aug. 2011.
70. Masahiro Hiasa, Masahiro Abe, 中野 綾子, Keiichiro Watanabe, Shingen Nakamura, Eiji Tanaka, Kenzo Asaoka and Toshio Matsumoto :
Pimキナーゼの阻害は骨芽細胞分化を促進し,骨髄腫骨病変の形成と腫瘍進展を抑制する,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 178, Jul. 2011.
71. Keiichiro Watanabe, Masahiro Abe, 川谷 誠, Masahiro Hiasa, Shingen Nakamura, Eiji Tanaka, 長田 裕之 and Toshio Matsumoto :
リベロマイシンAによる酸性環境がもたらす骨髄腫薬剤耐性の克服と骨病変形成の抑制,
The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 208, Jul. 2011.
72. Keiichiro Watanabe, Masahiro Abe, Cui Qu, Kawatani Makoto, Masahiro Hiasa, Nakano Ayako, Jinno Tadashi, Harada Takeshi, Shiroh Fujii, Shingen Nakamura, Miki Hirokazu, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki, Eiji Tanaka, Osada Hiroyuki and Toshio Matsumoto :
Reveromycin A prevents bone destruction and suppresses tumor growth in myeloma,
第72回日本血液学会, Dec. 2010.
73. Keiichiro Watanabe, Shingo Kuroda and Eiji Tanaka :
変則型Le Fort II型骨切りを用いて仮骨延長を行ったCrouzon症候群の一症例,
第69回日本矯正歯科学会大会, Oct. 2010.
74. Kumiko Kagawa, Jinno Tasashi, Harada Kakeshi, Cui Qu, Keiichiro Watanabe, Masahiro Hiasa, Oda Asuka, Amo Hiroe, Akishige Ikegame, Miki Hirokazu, Shiroh Fujii, Nakano Ayako, Kyoko Takeuchi, Shuji Ozaki, Masahiro Abe and Toshio Matsumoto :
Sensitization of hematopietic malignant cells to TRAIL with bortezomib and a TACE inhibitor,
第72回日本血液学会, Sep. 2010.
75. Shingen Nakamura, Masahiro Abe, Cui Qu, Keiichiro Watanabe, Akishige Ikegame, Masahiro Hiasa, Miki Hirokazu, Nakano Ayako, Oda Asuka, Amo Hiroe, Jinno Tasashi, Harada Takeshi, Shiroh Fujii, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki and Toshio Matsumoto :
Bortezomib-induced osteoblast differentiation is hampered by excessive ER stress,
第72回日本血液学会, Sep. 2010.
76. Masahiro Hiasa, Masahiro Abe, 中野 綾子, 小田 明日香, 天羽 宏枝, Kyoko Takeuchi, Kumiko Kagawa, Shingen Nakamura, 三木 浩和, Ken-ichiro Yata, Keiichiro Watanabe, Shuji Ozaki, Kenzo Asaoka, Eiji Tanaka and Toshio Matsumoto :
Bone marrow stromal cells supress TACE activity in monocytes to induce osteoclastogenesis,
第72回日本血液学会, Sep. 2010.
77. Cui Qu, Masahiro Abe, Miki Hirokazu, Shingen Nakamura, Keiichiro Watanabe, Akishige Ikegame, Masahiro Hiasa, Nakano Ayako, Jinnno Tadashi, Harada Takeshi, Shiroh Fujii, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki and Toshio Matsumoto :
Bone marrow stromal cells attenuate gama delta T,
第72回日本血液学会, Sep. 2010.
78. Masahiro Hiasa, Masahiro Abe, 中野 綾子, 小田 明日香, 天羽 宏枝, Kyoko Takeuchi, Kumiko Kagawa, Shingen Nakamura, 三木 浩和, Ken-ichiro Yata, Keiichiro Watanabe, Shuji Ozaki, Kenzo Asaoka, Eiji Tanaka and Toshio Matsumoto :
骨髄間質細胞は,単球のTACE活性を抑制し樹状細胞分化を抑制し破骨細胞文化を誘導する,
第28回日本骨代謝学会, Jul. 2010.
79. Keiichiro Watanabe, Masahiro Abe, Kawatani Makoto, Masahiro Hiasa, Shingen Nakamura, Eiji Tanaka, 長田 裕之 and Toshio Matsumoto :
リベロマイシンAは骨髄腫骨破壊病変の形成と腫瘍進展を抑制する,
第28回日本骨代謝学会, Jul. 2010.
80. Shingen Nakamura, Masahiro Abe, Cui Qu, Keiichiro Watanabe, Akishige Ikegame, Masahiro Hiasa, 三木 浩和, 中野 綾子, 小田 明日香, 天羽 宏枝, 神野 雅, 原田 武志, Shiroh Fujii, Kumiko Kagawa, Kyoko Takeuchi, Shuji Ozaki and Toshio Matsumoto :
ボルテゾミブによる骨芽細胞分化の促進は過剰な小胞体ストレスによって抑制される,
第28回日本骨代謝学会, Jul. 2010.
81. Ryoko Uchida, Akihiro Yasue, Keiichiro Watanabe, Rie Matsuda, 天地 良太, Shinya Horiuchi, 大西 正人, 高道 康宏 and Eiji Tanaka :
Clinical statistical study of jaw deformity patients in the Tokushima University Hospital, Orthodontic Clinic,
第53回中・四国矯正歯科学会学術大会, Jul. 2010.
82. 木島 毅, 鳥飼 勝行, 長西 裕樹, 錦織 なぎ, 大木 健作, Keiichiro Watanabe, Eiji Tanaka, Keiji Moriyama, 山本 真弓, 島崎 一夫, 米満 郁男 and 大村 進 :
梨状孔縁骨切・骨延長により中顔面の形態改善を図ったsyndromic craniosynostosisの1例,
第20回日本顎変形症学会総会 プログラム・抄録号, Vol.22, No.2, 152, Jun. 2010.
83. Keiichiro Watanabe, Nao Kinouchi, Saika Nakamura, Nobuhiko Kawai, Shingo Kuroda and Eiji Tanaka :
混合歯列期にLe Fort III型骨延長術を行ったCrouzon症候群男児の長期観察例,
第52回中・四国矯正歯科学会学術大会, Jul. 2009.
84. Kyoko Ishimoto, Shinji Fujihara, Nao Kinouchi, Tatsuya Nakamura, Teppei Watanabe, Keiichiro Watanabe, Yuko Kondo, Shingo Kuroda and Eiji Tanaka :
石本恭子,藤原慎視,木内奈央,中村竜也,渡邉哲平,渡邉佳一郎,近藤優子,黒田晋吾,田中栄二:片側性口唇裂・口蓋裂児の顎裂の重篤度が顎顔面の成長発育に影響を及ぼす,
第33回日本口蓋裂学会総会, May 2009.
85. Keiichiro Watanabe, Nao Kinouchi, Yuko Kondo, Tatsuya Nakamura, Kyoko Ishimoto, Teppei Watanabe, Shinji Fujihara, Shingo Kuroda and Eiji Tanaka :
5歳時における片側性及び両側性口唇・口蓋裂児の顎顔面形態の比較,
第33回日本口蓋裂学会総会, May 2009.
86. Teppei Watanabe, Yuko Kondo, Shinji Fujihara, Tatsuya Nakamura, Keiichiro Watanabe, Kyoko Ishimoto, Nao Kinouchi, Shingo Kuroda and Eiji Tanaka :
片側性口唇・口蓋裂児の顎裂の重篤度と上顎骨歯槽幅径の成長変化の関連性,
第33回日本口蓋裂学会総会, May 2009.

Et cetera, Workshop:

1. Ryota Amachi, Masahiro Abe, Keiichiro Watanabe, Kumiko Kagawa, Shiroh Fujii, 原田 武志, Hirokazu Miki, Keiichiro Watanabe, 小野 明日香, Masahiro Hiasa, Eiji Tanaka and Toshio Matsumoto :
骨髄腫の酸性環境はTRAIL受容体発現をエピジェネティックに抑制し,TRAIL抵抗性をもたらす,
第20回徳島骨代謝研究会, Nov. 2013.
2. Keiichiro Watanabe, Masahiro Abe and Toshio Matsumoto :
リベロマイシンAによる酸性環境がもたらす骨髄腫薬剤耐性の克服と骨病変形成の制御,
第15回癌と骨病変研究会, Nov. 2012.
3. Keiichiro Watanabe, Ryota Amachi, Masahiro Hiasa, Shingen Nakamura, Itsuro Endo, Hiroshi Mori, Eiji Tanaka and Toshio Matsumoto :
The cathepsinK inhibitor ONO-KK1-300-01 (ONO-KK1) prevents bone destruction and restores bone formation in myeloma bone lesions,
Bone Seminar, Aug. 2012.
4. Ryota Amachi, Masahiro Abe, Keiichiro Watanabe, Kumiko Kagawa, 藤井 志郎, 原田 武志, Hirokazu Miki, Shingen Nakamura, 小田 明日香, Masahiro Hiasa, Eiji Tanaka and Toshio Matsumoto :
酸環境は骨髄腫細胞のTRAILに対する抵抗性を増強する,
第3回骨バイオサイエンス研究会, Jul. 2012.
5. Masahiro Hiasa, Masahiro Abe, 中野 綾子, Keiichiro Watanabe, Kyoko Takeuchi, Kumiko Kagawa, Hirokazu Miki, Shingen Nakamura, Shiroh Fujii, 原田 武志, Shuji Ozaki, Eiji Tanaka, Kenzo Asaoka and Toshio Matsumoto :
Pimキナーゼの阻害による骨髄腫の進展抑制,
癌と骨病変研究会, Nov. 2011.
6. Keiichiro Watanabe, Masahiro Abe, 崔 衢, 川谷 誠, Masahiro Hiasa, 長田 裕之, Eiji Tanaka and Toshio Matsumoto :
A novel anti-resorptive agent, reveromycin A, ameliorates bone destruction and tumor growth in myeloma,
第2回骨バイオサイエンス研究会, Jul. 2011.
7. Masahiro Hiasa, Masahiro Abe, 中野 綾子, 小田 明日香, 天羽 宏枝, Kyoko Takeuchi, Kumiko Kagawa, Shingen Nakamura, 三木 浩和, Ken-ichiro Yata, Keiichiro Watanabe, Shuji Ozaki, Kenzo Asaoka, Eiji Tanaka and Toshio Matsumoto :
骨髄間質細胞は,単球のTACE活性を抑制し樹状細胞分化を抑制し破骨細胞文化を誘導する,
第17回徳島骨代謝研究会, Nov. 2010.
8. Keiichiro Watanabe, Masahiro Abe, 崔 衢, 川谷 誠, 長田 裕之, Eiji Tanaka and Toshio Matsumoto :
リベロマイシンAの骨髄腫骨病変と腫瘍進展抑制作用,
第1回骨バイオサイエンス研究会, Jun. 2010.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

  • 癌細胞の低酸素、酸性環境下における薬剤耐性に対する治療薬の開発 (Project/Area Number: 15K20536 )
  • Elucidation and overcoming of the drug resistance in cancer cells in the presence of the osteoclast. (Project/Area Number: 24890152 )
  • Search by Researcher Number (20634554)